18F-fluoromisonidazole uptake in advanced stage non-small cell lung cancer: A voxel-by-voxel PET kinetics study-Reference-Cited by-同舟云学术

18F-fluoromisonidazole uptake in advanced stage non-small cell lung cancer: A voxel-by-voxel PET kinetics study

Published:2017-07-21 Issue:9 Volume:44 Page:4665-4676
ISSN:0094-2405
Container-title:Medical Physics
language:en
Short-container-title:Med. Phys.

Author:

McGowan Daniel R.¹²,Macpherson Ruth E.³,Hackett Sara L.¹,Liu Dan¹,Gleeson Fergus V.¹³,McKenna W. Gillies¹⁴,Higgins Geoff S.¹⁴,Fenwick John D.¹

Affiliation:

1. Cancer Research UK/MRC Oxford Institute for Radiation Oncology; Gray Laboratories; Department of Oncology; University of Oxford; Oxford UK

2. Radiation Physics and Protection; Oxford University Hospitals NHS Foundation Trust; Oxford UK

3. Department of Radiology; Oxford University Hospitals NHS Foundation Trust; Oxford UK

4. Department of Oncology; Oxford University Hospitals NHS Foundation Trust; Oxford UK

Funder

National Institute for Health Research

Cancer Research UK

Cancer Research UK Clinician Scientist Award

Cancer Research UK Career Development Fellowship

Oxford ECMC

Oxford Cancer Imaging Centre

CRUK Oxford Centre

Novartis

Medical Research Council

Cancer Research UK/MRC Oxford Institute for Radiation Oncology

Publisher

Wiley

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mp.12416/fullpdf

Reference36 articles.

1. Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia;Rasey;Int J Radiat Oncol Biol Phys,1989

2. A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data;Casciari;Med Phys,1995

3. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy;Eschmann;J Nucl Med,2005

4. Hypoxia imaging with [18F]HX4 PET in NSCLC patients: defining optimal imaging parameters;Zegers;Radiother Oncol,2013

5. PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients;Bollineni;J Nucl Med,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluations of an Early Change in Tumor Pathophysiology in Response to Radiotherapy with Oxygen Enhanced Electron Paramagnetic Resonance Imaging (OE EPRI);Molecular Imaging and Biology;2024-06

2. Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients;Scientific Reports;2022-12-16

3. New PET Tracers: Current Knowledge and Perspectives in Lung Cancer;Seminars in Nuclear Medicine;2022-11

4. Radiogenomic analysis of primary breast cancer reveals [18F]-fluorodeoxglucose dynamic flux-constants are positively associated with immune pathways and outperform static uptake measures in associating with glucose metabolism;Breast Cancer Research;2022-05-17

5. Investigation of atovaquone-induced spatial changes in tumour hypoxia assessed by hypoxia PET/CT in non-small cell lung cancer patients;EJNMMI Research;2021-12